Identification of novel serum biomarkers for Alzheimer's disease screened by phage display library of random peptides
Journal of Alzheimer's Disease Reports · 2026-03 · 10
DOI: 10.1177/25424823261432141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer's Disease Reports, online erschienen am 10.03.2026. Verfasst von Dandan Gao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, Henan, China. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China Grants, the Key R&D Program of Henan Province.
Themen: Demenz
Abstract (Originalsprache)
Background
Identification of Alzheimer's disease (AD) needs inexpensive, noninvasive novel biomarkers. autoimmunity plays a key role in the pathogenesis of AD.
Objective
This study aims to screen innovative diagnostic biomarkers for AD from the perspective of autoantibodies.
Methods
The study consisted of two screening phases and two validation phases. AD serum autoantibody-related biomarkers were discovered and validated using serum samples from four independent cohorts encompassing 241 participants, i.e., AD patients, healthy controls, and other dementia-related diseases. First, to identify biomarkers for AD, a phage displayed random peptide library (Ph.D.12) was applied to screen specific autoantibodies in a total of 71 serum samples from 39 AD patients and 32 healthy controls. After further screening by polypeptide microarray, Then, for validation, three peptides were analyzed in another two independent cohorts, which included AD patients, healthy controls, and other dementia-related diseases, Enzyme-linked immunosorbent assay (ELISA) was finally used to evaluate their sensitivity and specificity for AD diagnosis.
Results
Our results show that both AD2024Val03, AD2024Val70, and AD2024Val72 showed a statistically significant ability to discriminate AD patients from controls and other dementia-related diseases. Additionally, combination of these three peptides, AD2024Val, could greatly improve the diagnostic performance (AUC is above 0.95, sensitivity ∼100%, specificity ∼79%). Conclusions the peptides we identified could serve as promising blood biomarkers for AD clinical diagnosis, which also might provide new insights into the potential pathogenesis of AD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, P.R.C. China.
- Department of Geriatrics, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
- Department of Neurology, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
- Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
ORCID-Profile: Dandan Gao, Fengyu Wang, Jiewen Zhang
Förderung
- National Natural Science Foundation of China Grants
- the Key R&D Program of Henan Province
Zitieren
APA
Gao, D., Han, Z., Ai, X., Wang, F., Lai, D., Gao, C., Zhang, Z., Tao, S., Shang, J., & Zhang, J. (2026). Identification of novel serum biomarkers for Alzheimer's disease screened by phage display library of random peptides. Journal of Alzheimer's Disease Reports, 10. https://doi.org/10.1177/25424823261432141
Vancouver
Gao D, Han Z, Ai X, Wang F, Lai D, Gao C, et al. Identification of novel serum biomarkers for Alzheimer's disease screened by phage display library of random peptides. Journal of Alzheimer's Disease Reports. 2026;10. doi:10.1177/25424823261432141
BibTeX
@article{Gao2026,
author = {Gao, Dandan and Han, Zhicheng and Ai, Xiaoyang and Wang, Fengyu and Lai, Danyun and Gao, Chenhao and Zhang, Zhaohui and Tao, Shengce and Shang, Junkui and Zhang, Jiewen},
title = {Identification of novel serum biomarkers for Alzheimer's disease screened by phage display library of random peptides},
journal = {Journal of Alzheimer's Disease Reports},
year = {2026},
volume = {10},
doi = {10.1177/25424823261432141}
}
EUVIMED